These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Pneumococcal vaccines: World Health Organization position paper. Can Commun Dis Rep; 1999 Sep; 25(17):150-1. PubMed ID: 10513118 [TBL] [Abstract][Full Text] [Related]
3. Surveillance of pneumococcal disease in Australian states and territories. McIntyre P; Menzies R; Krause V; Selvey L; Hall R; Misrachi A; Andrews R; Giele C; Gill J Commun Dis Intell; 2000 Apr; 24(4):93-5. PubMed ID: 10851796 [TBL] [Abstract][Full Text] [Related]
4. Understanding the link between pneumococcal serotypes and invasive disease. Soley C; Arguedas A Vaccine; 2009 Aug; 27 Suppl 3():C19-21. PubMed ID: 19535183 [TBL] [Abstract][Full Text] [Related]
5. Invasive pneumococcal disease among children in rural Bangladesh: results from a population-based surveillance. Arifeen SE; Saha SK; Rahman S; Rahman KM; Rahman SM; Bari S; Naheed A; Mannan I; Seraji MH; Ahmed NU; Hassan MS; Huda N; Siddik AU; Quasem I; Islam M; Fatima K; Al-Emran H; Brooks WA; Baqui AH; Breiman RF; Sack D; Luby SP Clin Infect Dis; 2009 Mar; 48 Suppl 2():S103-13. PubMed ID: 19191605 [TBL] [Abstract][Full Text] [Related]
6. Invasive pneumococcal disease in children 5 years after conjugate vaccine introduction--eight states, 1998-2005. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2008 Feb; 57(6):144-8. PubMed ID: 18272956 [TBL] [Abstract][Full Text] [Related]
7. Changing epidemiology of invasive pneumococcal disease among White Mountain Apache persons in the era of the pneumococcal conjugate vaccine. Lacapa R; Bliss SJ; Larzelere-Hinton F; Eagle KJ; McGinty DJ; Parkinson AJ; Santosham M; Craig MJ; O'Brien KL Clin Infect Dis; 2008 Aug; 47(4):476-84. PubMed ID: 18627249 [TBL] [Abstract][Full Text] [Related]
8. Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004. Hicks LA; Harrison LH; Flannery B; Hadler JL; Schaffner W; Craig AS; Jackson D; Thomas A; Beall B; Lynfield R; Reingold A; Farley MM; Whitney CG J Infect Dis; 2007 Nov; 196(9):1346-54. PubMed ID: 17922399 [TBL] [Abstract][Full Text] [Related]
9. Antibiotic resistance in Latin America: a cause for alarm. Valenzuela MT; de Quadros C Vaccine; 2009 Aug; 27 Suppl 3():C25-8. PubMed ID: 19540634 [TBL] [Abstract][Full Text] [Related]
10. Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease--United States, 1998-2003. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2005 Sep; 54(36):893-7. PubMed ID: 16163262 [TBL] [Abstract][Full Text] [Related]
11. Changing epidemiology of invasive pneumococcal disease in central Australia prior to conjugate vaccine: a 16-year study. Torzillo PJ; Morey F; Gratten M; Murphy D; Matters R; Dixon J Vaccine; 2007 Mar; 25(13):2375-8. PubMed ID: 17030079 [TBL] [Abstract][Full Text] [Related]
12. Epidemiology of invasive Streptococcus pneumoniae among Navajo children in the era before use of conjugate pneumococcal vaccines, 1989-1996. O'Brien KL; Shaw J; Weatherholtz R; Reid R; Watt J; Croll J; Dagan R; Parkinson AJ; Santosham M Am J Epidemiol; 2004 Aug; 160(3):270-8. PubMed ID: 15258000 [TBL] [Abstract][Full Text] [Related]
13. Epidemiology and prevention of pneumococcal disease. McIntyre P Commun Dis Intell; 1997 Feb; 21(4):41-6. PubMed ID: 9079592 [TBL] [Abstract][Full Text] [Related]
14. Herd immunity and pneumococcal conjugate vaccine: a quantitative model. Haber M; Barskey A; Baughman W; Barker L; Whitney CG; Shaw KM; Orenstein W; Stephens DS Vaccine; 2007 Jul; 25(29):5390-8. PubMed ID: 17583392 [TBL] [Abstract][Full Text] [Related]
15. Streptococcus pneumoniae: epidemiology, risk factors, and strategies for prevention. Lynch JP; Zhanel GG Semin Respir Crit Care Med; 2009 Apr; 30(2):189-209. PubMed ID: 19296419 [TBL] [Abstract][Full Text] [Related]
16. Surveillance for invasive pneumococcal disease during 2000-2005 in a population of children who received 7-valent pneumococcal conjugate vaccine. Black S; France EK; Isaacman D; Bracken L; Lewis E; Hansen J; Fireman B; Austrian R; Graepel J; Gray S; Klein NP Pediatr Infect Dis J; 2007 Sep; 26(9):771-7. PubMed ID: 17721369 [TBL] [Abstract][Full Text] [Related]
17. The coming of age of niche vaccines? Effect of vaccines on resistance profiles in Streptococcus pneumoniae. McGee L Curr Opin Microbiol; 2007 Oct; 10(5):473-8. PubMed ID: 17936680 [TBL] [Abstract][Full Text] [Related]
18. From global to regional: the importance of pneumococcal disease in Latin America. de Quadros CA Vaccine; 2009 Aug; 27 Suppl 3():C29-32. PubMed ID: 19540025 [TBL] [Abstract][Full Text] [Related]
19. [Invasive pneumococcal diseases in children and surveillance systems in Italy]. Bagnato B; Marino MG; Franco E Ig Sanita Pubbl; 2008; 64(6):811-22. PubMed ID: 19219089 [TBL] [Abstract][Full Text] [Related]
20. The epidemiology of childhood pneumococcal disease in the United States in the era of conjugate vaccine use. Toltzis P; Jacobs MR Infect Dis Clin North Am; 2005 Sep; 19(3):629-45. PubMed ID: 16102653 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]